Clinical significance of stanniocalcin 2 as a prognostic marker in gastric cancer

Annals of Surgical Oncology

Volumn 17, Issue 10, 2010, Pages 2601-2607

  Yokobori, Takehiko ^a,b   Mimori, Koshi ^a   Ishii, Hideshi ^a   Iwatsuki, Masaaki ^a   Tanaka, Fumiaki ^a   Kamohara, Yukio ^a   Ieta, Keisuke ^b   Kita, Yoshiaki ^a   Doki, Yuichiro ^c   Kuwano, Hiroyuki ^b   Mori, Masaki ^c  

^a KYUSHU UNIVERSITY   (Japan)

^b GUNMA UNIVERSITY   (Japan)

^c OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; HYPOCALCIN; SMALL INTERFERING RNA; STANNIOCALCIN 2; UNCLASSIFIED DRUG;

ARTICLE; CANCER GROWTH; CANCER PATIENT; CANCER TISSUE; CELL PROLIFERATION; CLINICAL FEATURE; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; HUMAN; HUMAN TISSUE; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; PROGNOSIS; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; RNA INTERFERENCE; STOMACH CANCER;

AGED; BLOTTING, WESTERN; CARCINOMA, SIGNET RING CELL; CELL PROLIFERATION; FEMALE; GLYCOPROTEINS; HUMANS; IMMUNOENZYME TECHNIQUES; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; LIVER NEOPLASMS; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOPLASM INVASIVENESS; PERITONEAL NEOPLASMS; PROGNOSIS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; RNA, SMALL INTERFERING; STOMACH; STOMACH NEOPLASMS; SURVIVAL RATE; UP-REGULATION;

EID: 78049476955     PISSN: 10689265     EISSN: 15344681     Source Type: Journal    
DOI: 10.1245/s10434-010-1086-0     Document Type: Article

References (26)

1. JR Kelley JM Duggan 2003 Gastric cancer epidemiology and risk factors J Clin Epidemiol. 56 1 9 10.1016/S0895-4356(02)00534-6 12589864
2. P Sun JB Xiang ZY Chen 2009 Meta-analysis of adjuvant chemotherapy after radical surgery for advanced gastric cancer Br J Surg. 96 26 33 1:STN:280:DC%2BD1M%2Fls1Onsg%3D%3D 10.1002/bjs.6408 19016271
3. Sasako M, Sano T, Yamamoto S, Kurokawa Y, Nashimoto A, Kurita A, et al. D2 lymphadenectomy alone or with para-aortic nodal dissection for gastric cancer. N Engl J Med. 2008;359:453-62.
4. M D'Errico E de Rinaldis MF Blasi V Viti M Falchetti A Calcagnile, et al. 2009 Genome-wide expression profile of sporadic gastric cancers with microsatellite instability Eur J Cancer. 45 461 469 10.1016/j.ejca.2008.10.032 19081245
5. K Ieta F Tanaka T Yokobori Y Kita N Haraguchi K Mimori, et al. 2009 Clinicopathological significance of stanniocalcin 2 gene expression in colorectal cancer Int J Cancer. 125 926 931 1:CAS:528:DC%2BD1MXnsFelurw%3D 10.1002/ijc.24453 19415750
6. GF Wagner EM Jaworski M Haddad 1998 Stanniocalcin in the seawater salmon: structure, function, and regulation Am J Physiol. 274 R1177 R1185 1:CAS:528:DyaK1cXivFShsb4%3D 9575986
7. AC Chang RR Reddel 1998 Identification of a second stanniocalcin cDNA in mouse and human: stanniocalcin 2 Mol Cell Endocrinol. 141 95 99 1:CAS:528:DyaK1cXltlKru74%3D 10.1016/S0303-7207(98)00097-5 9723890
8. K Ishibashi M Imai 2002 Prospect of a stanniocalcin endocrine/paracrine system in mammals Am J Physiol Renal Physiol. 282 F367 F375 1:CAS:528: DC%2BD38Xit1Ggt74%3D 11832417
9. AC Chang DA Jellinek RR Reddel 2003 Mammalian stanniocalcins and cancer Endocr Relat Cancer. 10 359 373 1:CAS:528:DC%2BD3sXpsFylu7s%3D 10.1677/erc.0.0100359 14503913
10. S Volland W Kugler L Schweigerer J Wilting J Becker 2009 Stanniocalcin 2 promotes invasion and is associated with metastatic stages in neuroblastoma Int J Cancer. 125 2049 2057 1:CAS:528:DC%2BD1MXhtVOms7rF 10.1002/ijc.24564 19582875
11. K Tamura M Furihata SY Chung M Uemura H Yoshioka T Iiyama, et al. 2009 Stanniocalcin 2 overexpression in castration-resistant prostate cancer and aggressive prostate cancer Cancer Sci. 100 914 919 1:CAS:528: DC%2BD1MXls1Srur4%3D 10.1111/j.1349-7006.2009.01117.x 19298603
12. HA Meyer A Tolle M Jung FR Fritzsche B Haendler I Kristiansen, et al. 2009 Identification of stanniocalcin 2 as prognostic marker in renal cell carcinoma Eur Urol. 55 669 678 1:CAS:528:DC%2BD1MXns1Cks7k%3D 10.1016/j.eururo.2008.04.001 18450365
13. T Bouras MC Southey AC Chang RR Reddel D Willhite R Glynne, et al. 2002 Stanniocalcin 2 is an estrogen-responsive gene coexpressed with the estrogen receptor in human breast cancer Cancer Res. 62 1289 1295 1:CAS:528: DC%2BD38Xit1KhtL4%3D 11888893
14. J Yamamura Y Miyoshi Y Tamaki T Taguchi K Iwao M Monden, et al. 2004 mRNA expression level of estrogen-inducible gene, alpha 1-antichymotrypsin, is a predictor of early tumor recurrence in patients with invasive breast cancers Cancer Sci. 95 887 892 1:CAS:528:DC%2BD2MXot1OktA%3D%3D 10.1111/j.1349-7006. 2004.tb02198.x 15546506
15. S Esseghir A Kennedy P Seedhar A Nerurkar R Poulsom JS Reis-Filho, et al. 2007 Identification of NTN4, TRA1, and STC2 as prognostic markers in breast cancer in a screen for signal sequence encoding proteins Clin Cancer Res. 13 3164 3173 1:CAS:528:DC%2BD2sXmtVajtbY%3D 10.1158/1078-0432.CCR-07-0224 17545519
16. TA Masuda H Inoue H Sonoda S Mine Y Yoshikawa K Nakayama, et al. 2002 Clinical and biological significance of S-phase kinase-associated protein 2 (Skp2) gene expression in gastric carcinoma: modulation of malignant phenotype by Skp2 overexpression, possibly via p27 proteolysis Cancer Res. 62 3819 3825 1:CAS:528:DC%2BD38XltF2jurY%3D 12097295
17. K Ogawa T Utsunomiya K Mimori F Tanaka H Inoue H Nagahara, et al. 2005 Clinical significance of human kallikrein gene 6 messenger RNA expression in colorectal cancer Clin Cancer Res. 11 2889 2893 1:CAS:528:DC%2BD2MXjtlejtrc%3D 10.1158/1078-0432.CCR-04-2281 15837738
18. K Ieta F Tanaka T Utsunomiya H Kuwano M Mori 2006 CEACAM6 gene expression in intrahepatic cholangiocarcinoma Br J Cancer. 95 532 540 1:CAS:528: DC%2BD28XotV2rurY%3D 10.1038/sj.bjc.6603276 16868542
19. A Goldhirsch JH Glick RD Gelber AS Coates HJ Senn 2001 Meeting highlights: International Consensus Panel on the Treatment of Primary Breast Cancer. Seventh International Conference on Adjuvant Therapy of Primary Breast Cancer J Clin Oncol. 19 3817 3827 1:STN:280:DC%2BD3Mrht1Slsw%3D%3D 11559719
20. A Goldhirsch WC Wood RD Gelber AS Coates B Thürlimann HJ Senn 2007 Progress and promise: highlights of the international expert consensus on the primary therapy of early breast cancer 2007 Ann Oncol. 18 1133 1144 1:STN:280:DC%2BD2svlvVSkuw%3D%3D 10.1093/annonc/mdm271 17675394
21. AC Chang J Hook FA Lemckert MM McDonald MA Nguyen EC Hardeman, et al. 2008 The murine stanniocalcin 2 gene is a negative regulator of postnatal growth Endocrinology. 149 2403 2410 1:CAS:528:DC%2BD1cXht1GmsLbK 10.1210/en.2007-1219 18258678
22. AD Gagliardi EY Kuo S Raulic GF Wagner GE DiMattia 2005 Human stanniocalcin-2 exhibits potent growth-suppressive properties in transgenic mice independently of growth hormone and IGFs Am J Physiol Endocrinol Metab. 288 E92 E105 1:CAS:528:DC%2BD2MXhtVGjur8%3D 10.1152/ajpendo.00268.2004 15367391
23. D Ito JR Walker CS Thompson I Moroz W Lin ML Veselits, et al. 2004 Characterization of stanniocalcin 2, a novel target of the mammalian unfolded protein response with cytoprotective properties Mol Cell Biol. 24 9456 9469 1:CAS:528:DC%2BD2MXltl2isw%3D%3D 10.1128/MCB.24.21.9456-9469.2004 15485913
24. AY Law CK Wong 2010 Stanniocalcin-2 is a HIF-1 target gene that promotes cell proliferation in hypoxia Exp Cell Res. 316 466 476 1:CAS:528: DC%2BD1MXhs1WgtbjI 10.1016/j.yexcr.2009.09.018 19786016
25. K Joensuu P Heikkila LC Andersson 2008 Tumor dormancy: elevated expression of stanniocalcins in late relapsing breast cancer Cancer Lett. 265 76 83 1:CAS:528:DC%2BD1cXlvFyhsLc%3D 10.1016/j.canlet.2008.02.022 18355956
26. RJ Buckanovich D Sasaroli A O'Brien-Jenkins J Botbyl R Hammond D Katsaros, et al. 2007 Tumor vascular proteins as biomarkers in ovarian cancer J Clin Oncol. 25 852 861 1:CAS:528:DC%2BD2sXjvVKmtLg%3D 10.1200/JCO.2006.08.8583 17327606